Pharmaceuticals, Biotechnology and Life Sciences
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) (along with its subsidiaries together…
With up to six years of follow-up, results from the RESONATETM study showed patients with previously treated CLL receiving ibrutinib…
Dr. Summers to help guide Cerevance’s Drug Discovery and Development Efforts BOSTON–(BUSINESS WIRE)–#CNS–Cerevance, a clinical stage biopharmaceutical company advancing new…
Acquisition allows KD Pharma to further expand its leading position in the omega-3 pharmaceutical market BIOGGIO, Switzerland–(BUSINESS WIRE)–KD Pharma Group…
New ovarian cancer test combines AI and Mass Spec in an effort to better identify cancerous ovarian tumors from benign…
ZYNTEGLO is the first gene therapy approved for transfusion-dependent β-thalassemia (TDT) European marketing authorization for ZYNTEGLO follows the fastest assessment…
ZYNTEGLO is the first gene therapy approved for transfusion-dependent β-thalassemia (TDT) European marketing authorization for ZYNTEGLO follows the fastest assessment…
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–#INDstatus—PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for…
Starpharma has signed a Development and Option Agreement with AstraZeneca to progress the development of a Dendrimer Enhanced Product (DEP®)…
Analytics platform powers better patient outcomes, lower cost of care, and reduced time-to-market SAN FRANCISCO–(BUSINESS WIRE)–Clarify Health Solutions, Inc., a…